Board of Directors
PROF. SAEID ESMAEILZADEH
Chairman of the board
Saeid is a serial entrepreneur having established and managed a range of research-intensive companies in various industries. In 2002 he became the youngest associate professor in Sweden. He has received many distinctions and awards for his research as well as for his achievements as an entrepreneur. Saeid is an experienced board member and since 2010 has been the CEO of Serendipity Innovations. Saeid has a Ph.D. in Materials Chemistry from Stockholm University.
PROF. MARIS HARTMANIS
Maris is a seasoned industrial executive and leader with almost 30 years of CEO, senior R&D management and Board of Director experience from the international Life Science area. His experience stems from large organizations, as well as entrepreneurial start-ups. Most recently he was the CEO of two Swedish public pharmaceutical companies. Maris has a Ph.D. degree in Biochemistry from the Royal Institute of Technology in Stockholm, where he also is an Associate Professor.
Karin has a broad experience of the international pharmaceutical industry from senior positions within regulatory, pharmaceutical and analytical R&D, project leadership as well as clinical. Most recently Karin held the position of Global Head and Vice President of Clinical Development at AstraZeneca.
PROF. PETER EDMAN
Professor Peter Edman has an extensive experience in drug development from the pharmaceutical industry and has held a number of senior research leadership positions within Orexo, Sobi, Biovitrum, AstraZeneca, Astra and Pharmacia. He has also held a position as Associate Professor at the Swedish Medical Product Agency. In addition, Peter has been Professor in Pharmaceutical Formulation and Adjunct Professor in Drug Delivery at the Faculty of Pharmacy, University of Uppsala.
Giorgio is educated in finance and business administration at the University Luigi Bocconi in Italy and operates as Head of Mergers & Acquisitions at UBI Banca SpA. Giorgio also has a board assignment for Axxam SpA.
Alessandro is educated in biology at Pavia University in Italy and operates as CEO of Axxam SpA. Alessandro also has board assignments for FEDERCHIMICA, Italian Association of Business Angels, ALISEI and Externautics SpA.